Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
SUM229PE
TNBC
-
PS-1145
IKK
NFKB
7537.065
uM
inf
inf
0.9458 0.9458 0.0000 0.0214
0.0000
1.8673
SUM229PE
TNBC
-
PS-1145
IKK
NFKB
7535.065
uM
inf
inf
0.8601 0.8601 0.0000 0.0395
0.4816
0.8663
SUM229PE
TNBC
-
Purvalanol A
CDK1
CDK
7537.067
uM
15.44060
22.47980
0.0008 -0.1830 0.8305 0.2246
0.9827
1.9773
SUM229PE
TNBC
-
Ribavirin
15359.211
uM
inf
inf
0.9761 0.9761 0.0000 -0.0092
-0.0004
1.4356
SUM229PE
TNBC
-
SB-3CT
MMP2/9
MMP
11058.144
uM
inf
24.86070
0.7399 0.7396 4.9787 0.0191
0.8029
2.1171
SUM229PE
TNBC
-
Selumetinib
MEK
MAPK
11058.155
uM
0.12678
0.34222
-0.2593 -0.3136 0.4903 0.5118
0.9872
2.0706
SUM229PE
TNBC
-
Sigma A6730
AKT
AKT
11058.158
uM
13.91380
24.25360
-0.7786 -1.0000 1.9770 0.2430
0.9723
2.1018
SUM229PE
TNBC
-
Sirolimus
MTOR
MTOR
7536.068
uM
1.64030
36.44280
-0.5080 -1.0000 0.3543 0.4649
0.6373
0.6416
SUM229PE
TNBC
-
Sirolimus
MTOR
MTOR
7537.069
uM
12.9580
27.13880
-0.1558 -1.0000 1.4861 0.1864
0.9046
1.9773
SUM229PE
TNBC
-
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
7537.084
uM
inf
inf
0.7245 0.7245 0.0000 0.1075
0.4618
1.8684
SUM229PE
TNBC
-
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7537.067
uM
4.64840
8.89610
-0.8964 -0.9530 1.6435 0.4847
0.9939
1.9773
SUM229PE
TNBC
-
Taxol
TUBB
TUBB
9860.002
uM
0.01019
0.01060
-0.1600 -0.1090 5.0000 0.6820
0.9944
1.5734
SUM229PE
TNBC
-
Taxol
TUBB
TUBB
13062.002
uM
0.01884
0.01879
-0.0381 0.0024 1.9806 0.5656
0.9950
1.6470
SUM229PE
TNBC
-
Taxol
TUBB
TUBB
13009.002
uM
0.01925
0.02034
-0.0938 -0.0708 2.3909 0.6076
0.9968
1.3417
SUM229PE
TNBC
-
TCS 2312
CHK1
CHK
11058.152
uM
1.43460
1.3490
0.0432 0.0560 1.9332 0.2208
0.9955
2.0809
SUM229PE
TNBC
-
TCS PIM-1 1
Pim kinase
PIM
11058.135
uM
30.59770
24.63560
0.3144 0.3142 4.5665 0.1064
0.9924
2.1492
SUM229PE
TNBC
-
Temsirolimus
MTOR
MTOR
11058.144
uM
21.79610
41.83750
-0.7969 -1.0000 1.6848 0.2681
0.9656
2.1171
SUM229PE
TNBC
-
Topotecan
TOP1
TOP
7536.078
uM
0.04635
0.07005
-0.3942 -0.4389 1.5257 0.8485
0.9492
1.1676
SUM229PE
TNBC
-
Topotecan
TOP1
TOP
9860.121
uM
0.08155
0.09854
-0.1151 -0.1662 1.5158 0.6512
0.9630
1.7546
SUM229PE
TNBC
-
Torkinib
15359.211
uM
0.31876
0.27769
0.0625 0.0286 0.4271 0.4000
0.8823
1.4356
SUM229PE
TNBC
-
Tozasertib
AURK/FLT3/ABL/JAK2
AURK
11058.15
uM
0.66944
7.31880
-0.4038 -1.0000 0.4593 0.3571
0.9590
2.2684
SUM229PE
TNBC
-
TPCA-1
IKK
NFKB
7535.1
uM
1.4270
1.85450
-0.4419 -0.3288 1.9288 0.4688
0.9791
0.8740
SUM229PE
TNBC
-
Trametinib
MEK
MAPK
7536.05
uM
0.00737
0.00936
-0.1214 -0.0803 0.6249 0.6217
0.9373
0.9494
SUM229PE
TNBC
-
Trametinib
MEK
MAPK
9860.012
uM
0.00679
0.01303
-0.2937 -0.2993 0.7194 0.7184
0.9957
1.7144
SUM229PE
TNBC
-
Trichostatin A
HDAC
HDAC
7537.065
uM
12.70040
19.70280
-0.8200 -0.7699 2.1225 0.7700
0.9975
1.8673